Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 22, 2025 02:17 ET | Source: Karolinska Development AB (publ)

Karolinska Developments portföljbolag SVF Vaccines planerar notering på Nasdaq First North Premier genom ett omvänt förvärv inför accelererad vaccinutveckling

STOCKHOLM, 22 december 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att portföljbolaget SVF Vaccines AB har ingått en icke-bindande avsiktsförklaring med Novakand Pharma AB...
December 22, 2025 02:17 ET | Source: Karolinska Development AB (publ)

Karolinska Development’s portfolio company SVF Vaccines plans for listing on Nasdaq First North Premier through reverse takeover ahead of accelerated vaccine development

STOCKHOLM, Sweden, December 22, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines has signed a non-binding letter of intent (LOI) with Novakand...
March 11, 2021 05:33 ET | Source: Research and Markets

Global COVID-19 Vaccine Market 2021-2026: Current Trends, Pipeline Products, Clinical Trials and Leading Players

Dublin, March 11, 2021 (GLOBE NEWSWIRE) -- The "SARS-CoV-2 COVID Vaccine Market Analysis & Forecast to 2026" report has been added to ResearchAndMarkets.com's offering. This report provides a...